Generic name: HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN 20ug in 0.5mL, HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN RESIDUES 2-472 ANTIGEN 20ug in 0.5mL
Dosage form: injection, suspension
Medically reviewed on January 15, 2018.
Preparation for Administration
Shake vial or syringe well before withdrawal and use. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If either of these conditions exists, the vaccine should not be administered. With thorough agitation, CERVARIX is a homogeneous, turbid, white suspension. Do not administer if it appears otherwise.
Dose and Schedule
Immunization with CERVARIX consists of 3 doses of 0.5-mL each, by intramuscular injection according to the following schedule: 0, 1, and 6 months. The preferred site of administration is the deltoid region of the upper arm.
Do not administer this product intravenously, intradermally, or subcutaneously.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Cervarix (human papillomavirus vaccine)
- Cervarix Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- 0 Reviews
- Drug class: viral vaccines